Figure 2.

Comparisons of sclerostin serum levels in ankylosing spondylitis (AS) patients at baseline, 6 months and 12 months after anti-TNF therapy and in healthy controls.

Saad et al. Arthritis Research & Therapy 2012 14:R216   doi:10.1186/ar4055
Download authors' original image